Dutasteride Capsule, Liquid Filled
Product Images NDC 71205-278

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Dutasteride (NDC 71205-278). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

71205-278-90 (90ct)

This is a bottle of Dutasteride 0.5mg, containing 90 capsules. The capsules are yellow and oblong, with each capsule containing 0.5mg of the active ingredient dutasteride. The label displays a product ID of SD027890, lot number of 00000, and an expiration date of 00/00/00. There is a manufacturer warning, which can be found on the bottle, and the medication should be stored at a temperature of 20° to 25°C (68° to 77°F). The bottle was relabeled by Proficient Rx LP in Thousand Oaks, CA, and the original manufacturer is Ascent Pharmaceuticals, Inc. situated in Central Isip, NY. Lastly, it is noteworthy to keep this medication away from children.*

FDA Label Image

Fig1 (Fig1)

FDA Label Image

Fig2 (Fig2)

FDA Label Image

Fig3 (Fig3)

FDA Label Image

Fig4 (Fig4)

FDA Label Image

Fig5 (Fig5)

FDA Label Image

Fig6 (Fig6)

FDA Label Image

Fig7 (Fig7)

FDA Label Image

Structure (Structure)

FDA Label Image

Tab1 (Tab1)

This is a chart comparing the onset time of adverse reactions of Dutasteride and Placebo within the span of 24 months. Specific adverse reactions and their percentages over time are listed, including impotence, decreased libido, ejaculation disorders, and breast disorders. The chart shows that Dutasteride has higher percentages of adverse reactions in all categories compared to Placebo.*

FDA Label Image

Tab2 (Tab2)

This text appears to be a report on adverse reactions to some medications. It lists various medications, and for each one, it provides the percentage of patients who experienced certain adverse reactions, such as ejaculation disorders, impotence, decreased libido, breast disorders, and dizziness. The data is broken down by the time of onset and the length of treatment.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.